{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:41:34Z","timestamp":1791196894193,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:00:00Z","timestamp":1386633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:00:00Z","timestamp":1386633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00198-013-2582-4","type":"journal-article","created":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T09:14:24Z","timestamp":1386580464000},"page":"737-745","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case\u2013control study in the CPRD"],"prefix":"10.1007","volume":"25","author":[{"given":"C.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. M.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Borer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,10]]},"reference":[{"key":"2582_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1056\/NEJMoa022436","volume":"350","author":"PJ Meunier","year":"2004","unstructured":"Meunier PJ, Roux C, Seeman E et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459\u2013468","journal-title":"N Engl J Med"},{"key":"2582_CR2","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/art.23461","volume":"58","author":"J-Y Reginster","year":"2008","unstructured":"Reginster J-Y, Felsenberg D, Boonen S et al (2008) Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum 58:1687\u20131695","journal-title":"Arthritis Rheum"},{"key":"2582_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1210\/jc.2012-3048","volume":"98","author":"JM Kaufman","year":"2013","unstructured":"Kaufman JM, Audran M, Bianchi G et al (2013) Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab 98:592\u2013601","journal-title":"J Clin Endocrinol Metab"},{"key":"2582_CR4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2012-202231","volume":"72","author":"JY Reginster","year":"2013","unstructured":"Reginster JY, Badurski J, Bellamy N et al (2013) Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann Rheum Dis 72:179\u2013186","journal-title":"Ann Rheum Dis"},{"key":"2582_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1185\/03007995.2011.648758","volume":"28","author":"C Cooper","year":"2012","unstructured":"Cooper C, Reginster J-Y, Chapurlat R et al (2012) Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of a randomised double-blind, placebo-controlled trial. Curr Med Res Opin 28:231\u2013239","journal-title":"Curr Med Res Opin"},{"key":"2582_CR6","unstructured":"European Medicines Agency (2013) PSUR assessment report\u2014strontium ranelate. www.ema.europa.eu. Accessed 27 Aug 2013"},{"key":"2582_CR7","unstructured":"European Medicines Agency (2006) Summary of product characteristics. Protelos. European Medicines Agency. http:\/\/www.ema.europa.eu. Accessed 19 Sept 2013"},{"key":"2582_CR8","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s00296-012-2594-y","volume":"33","author":"M Audran","year":"2013","unstructured":"Audran M, Jakob FJ, Palacios S et al (2013) A large prospective European cohort study of patients treated with strontium ranelate and followed up over 3\u00a0years. Rheumatol Int 33:2231\u20132239","journal-title":"Rheumatol Int"},{"key":"2582_CR9","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.3399\/bjgp10X483562","volume":"60","author":"NF Khan","year":"2010","unstructured":"Khan NF, Harrison SE, Rose PW (2010) Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 60:e128\u2013e136","journal-title":"Br J Gen Pract"},{"key":"2582_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","volume":"69","author":"E Herrett","year":"2010","unstructured":"Herrett E, Thomas SL, Schoonen WM et al (2010) Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 69:4\u201314","journal-title":"Br J Clin Pharmacol"},{"key":"2582_CR11","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1161\/01.CIR.101.22.2572","volume":"101","author":"C Varas-Lorenzo","year":"2000","unstructured":"Varas-Lorenzo C, Garcia-Rodriguez LA, Perez-Gutthann S et al (2000) Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case\u2013control study. Circulation 101:2572\u20132578","journal-title":"Circulation"},{"key":"2582_CR12","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/pds.1672","volume":"17","author":"TA Hammad","year":"2008","unstructured":"Hammad TA, McAdams MA, Feight A et al (2008) Determining the predictive value of Read\/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database. Pharmacoepidemiol Drug Saf 17:1197\u20131201","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2582_CR13","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00125-008-1076-y","volume":"51","author":"HE Mulnier","year":"2008","unstructured":"Mulnier HE, Seaman HE, Raleigh VS et al (2008) Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database. Diabetologia 51:1639\u20131645","journal-title":"Diabetologia"},{"key":"2582_CR14","unstructured":"National Institute for Health and Clinical Excellence (2011) Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. NICE technology appraisal guidance TA160. National Institute for Health and Clinical Excellence. www.nice.org.uk\/TA160. Accessed 29 Aug 2013"},{"key":"2582_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00198-012-2213-5","volume":"24","author":"JH Kang","year":"2013","unstructured":"Kang JH, Keller JJ, Lin HC (2013) Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study. Osteoporos Int 24:271\u2013277","journal-title":"Osteoporos Int"},{"key":"2582_CR16","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","volume":"28","author":"I Graham","year":"2007","unstructured":"Graham I, Atar D, Borch-Johnsen K et al (2007) European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 28:2375\u20132414","journal-title":"Eur Heart J"},{"key":"2582_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrrheum.2012.120","volume":"8","author":"CE Lampropoulos","year":"2012","unstructured":"Lampropoulos CE, Papaioannou I, D\u2019Cruz DP (2012) Osteoporosis\u2014a risk factor for cardiovascular disease? Nat Rev Rheumatol 8:587\u2013598","journal-title":"Nat Rev Rheumatol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2582-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-013-2582-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2582-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2582-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:26:00Z","timestamp":1630549560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-013-2582-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,10]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["2582"],"URL":"https:\/\/doi.org\/10.1007\/s00198-013-2582-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,10]]},"assertion":[{"value":"11 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}